JP2018511613A5 - - Google Patents

Download PDF

Info

Publication number
JP2018511613A5
JP2018511613A5 JP2017552060A JP2017552060A JP2018511613A5 JP 2018511613 A5 JP2018511613 A5 JP 2018511613A5 JP 2017552060 A JP2017552060 A JP 2017552060A JP 2017552060 A JP2017552060 A JP 2017552060A JP 2018511613 A5 JP2018511613 A5 JP 2018511613A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
cancer
diazaspiro
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017552060A
Other languages
English (en)
Japanese (ja)
Other versions
JP6737533B2 (ja
JP2018511613A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/025345 external-priority patent/WO2016161160A1/en
Publication of JP2018511613A publication Critical patent/JP2018511613A/ja
Publication of JP2018511613A5 publication Critical patent/JP2018511613A5/ja
Application granted granted Critical
Publication of JP6737533B2 publication Critical patent/JP6737533B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017552060A 2015-04-03 2016-03-31 スピロ環式化合物 Expired - Fee Related JP6737533B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562142946P 2015-04-03 2015-04-03
US62/142,946 2015-04-03
PCT/US2016/025345 WO2016161160A1 (en) 2015-04-03 2016-03-31 Spirocyclic compounds

Publications (3)

Publication Number Publication Date
JP2018511613A JP2018511613A (ja) 2018-04-26
JP2018511613A5 true JP2018511613A5 (cg-RX-API-DMAC7.html) 2019-05-09
JP6737533B2 JP6737533B2 (ja) 2020-08-12

Family

ID=57007413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017552060A Expired - Fee Related JP6737533B2 (ja) 2015-04-03 2016-03-31 スピロ環式化合物

Country Status (25)

Country Link
US (3) US10525036B2 (cg-RX-API-DMAC7.html)
EP (1) EP3277690B1 (cg-RX-API-DMAC7.html)
JP (1) JP6737533B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170132307A (cg-RX-API-DMAC7.html)
CN (1) CN107849053B (cg-RX-API-DMAC7.html)
AU (1) AU2016242940B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017021194A2 (cg-RX-API-DMAC7.html)
CA (1) CA2981055A1 (cg-RX-API-DMAC7.html)
CY (1) CY1123019T1 (cg-RX-API-DMAC7.html)
DK (1) DK3277690T3 (cg-RX-API-DMAC7.html)
ES (1) ES2788160T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20200805T1 (cg-RX-API-DMAC7.html)
HU (1) HUE049481T2 (cg-RX-API-DMAC7.html)
IL (1) IL254662B (cg-RX-API-DMAC7.html)
LT (1) LT3277690T (cg-RX-API-DMAC7.html)
MX (1) MX379622B (cg-RX-API-DMAC7.html)
PL (1) PL3277690T3 (cg-RX-API-DMAC7.html)
PT (1) PT3277690T (cg-RX-API-DMAC7.html)
RS (1) RS60340B1 (cg-RX-API-DMAC7.html)
RU (1) RU2745069C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201707911VA (cg-RX-API-DMAC7.html)
SI (1) SI3277690T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202000279T1 (cg-RX-API-DMAC7.html)
TW (1) TWI705067B (cg-RX-API-DMAC7.html)
WO (1) WO2016161160A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106999451B (zh) * 2014-09-17 2021-04-02 里科瑞尔姆Ip控股有限责任公司 双环化合物
HUE049481T2 (hu) 2015-04-03 2020-09-28 Recurium Ip Holdings Llc Spirociklusos vegyületek
CN109890827A (zh) * 2016-10-05 2019-06-14 芝诺罗耶尔蒂里程碑有限责任公司 螺环化合物
US10093664B2 (en) * 2016-12-08 2018-10-09 Board Of Regents, The University Of Texas System Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
BR112020015666A2 (pt) * 2018-01-31 2021-02-23 Aptinyx Inc. moduladores de espiro-lactamas de receptores nmda e usos dos mesmos
CA3137152A1 (en) 2019-04-18 2020-10-22 The Johns Hopkins University Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a] pyridine derivatives and use thereof
US11560366B2 (en) 2019-10-21 2023-01-24 Board Of Regents, The University Of Texas System Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
CN115124542A (zh) * 2022-07-08 2022-09-30 河南师范大学 羟基苯取代吡唑酮并吲唑[螺]吡唑酮类化合物的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR057579A1 (es) * 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
US8546404B2 (en) 2005-12-13 2013-10-01 Merck Sharp & Dohme Compounds that are ERK inhibitors
EP2086974B1 (en) 2006-11-17 2013-07-24 Polyera Corporation Diimide-based semiconductor materials and methods of preparing and using the same
US8716483B2 (en) 2008-02-21 2014-05-06 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
US20110166124A1 (en) 2008-07-23 2011-07-07 Mccormick Kevin D Tricyclic spirocycle derivatives and methods of use
EP2483263B1 (en) 2009-09-30 2018-07-18 Merck Sharp & Dohme Corp. Heterocyclic compounds that are erk inhibitors
CA3044884A1 (en) 2009-12-07 2011-06-16 Arbutus Biopharma Corporation Compositions for nucleic acid delivery
ES2609579T3 (es) 2011-08-29 2017-04-21 VIIV Healthcare UK (No.5) Limited Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
CN103130775B (zh) * 2011-11-22 2015-09-30 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的吲哚满酮衍生物
US8987264B2 (en) * 2012-11-09 2015-03-24 Bristol-Myers Squibb Company 1,3,5-triazine derivatives of spiro bicyclic oxalamide-compounds for treatment of hepatitis C
JP6506248B2 (ja) 2013-03-14 2019-04-24 ゾーン・ロイヤリティズ・アンド・マイルストーンズ・エルエルシー 二環式鎮痛化合物
CN105732636B (zh) 2014-12-30 2020-04-21 广东东阳光药业有限公司 杂芳化合物及其在药物中的应用
HUE049481T2 (hu) 2015-04-03 2020-09-28 Recurium Ip Holdings Llc Spirociklusos vegyületek
CN109890827A (zh) 2016-10-05 2019-06-14 芝诺罗耶尔蒂里程碑有限责任公司 螺环化合物

Similar Documents

Publication Publication Date Title
JP2018511613A5 (cg-RX-API-DMAC7.html)
RU2017133973A (ru) Спироциклические соединения
JP2018530591A5 (cg-RX-API-DMAC7.html)
JP7676141B2 (ja) ジヒドロオキサジアジノン
JP2017500364A5 (cg-RX-API-DMAC7.html)
JP2020530446A5 (cg-RX-API-DMAC7.html)
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
JP2009524670A5 (cg-RX-API-DMAC7.html)
JP2007510689A5 (cg-RX-API-DMAC7.html)
JP2012532931A5 (cg-RX-API-DMAC7.html)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2020515575A5 (cg-RX-API-DMAC7.html)
JP2018515555A5 (cg-RX-API-DMAC7.html)
JP2021500335A5 (cg-RX-API-DMAC7.html)
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
JP2011507849A5 (cg-RX-API-DMAC7.html)
JP2018522046A5 (cg-RX-API-DMAC7.html)
JP2018535999A5 (cg-RX-API-DMAC7.html)
JP2009541311A5 (cg-RX-API-DMAC7.html)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2016500073A5 (cg-RX-API-DMAC7.html)
CA2642922A1 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
EP3661560A1 (en) Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
JP2017530185A5 (cg-RX-API-DMAC7.html)
RU2012134306A (ru) Азотосодержащие производные гетероарилов